CJC-1295 with Ipamorelin research peptide vial

CJC-1295 with IPAMORELIN

£64.99
Sale price  £64.99 Regular price 
Skip to product information
CJC-1295 with Ipamorelin research peptide vial

CJC-1295 with IPAMORELIN

£64.99
Sale price  £64.99 Regular price 

CJC-1295 with Ipamorelin combines two distinct growth-hormone-secretagogue research peptides in a single 10 mg vial: CJC-1295, a GHRH-receptor analogue, and Ipamorelin, a selective ghrelin-receptor (GHS-R1a) agonist. Researchers study the two compounds together to examine their complementary activity across these two separate growth-hormone-release pathways. Reliable Research Labs supplies this blend from the UK strictly for qualified laboratory research — see "About CJC-1295 with Ipamorelin" below for further scientific background.
FOR LABORATORY RESEARCH USE ONLY

Not Intended for Human or Animal Consumption

PRODUCT SPECIFICATIONS

  • Quantity: 10 mg
  • Appearance: Lyophilized (Freeze-Dried) Powder
  • Purity: ≥99.6% (Confirmed by HPLC Analysis)

RESEARCH USE

This material is supplied exclusively for laboratory-based, in vitro research conducted by qualified professionals. It is not approved for use in humans or animals and must not be incorporated into pharmaceuticals, dietary supplements, food products, cosmetics, or diagnostic applications.

IMPORTANT NOTICE

This product has not been reviewed or approved by the U.S. Food and Drug Administration (FDA). No claims are made regarding safety, efficacy, or therapeutic benefit. It is not intended to diagnose, treat, cure, or prevent any medical condition. Researchers are responsible for ensuring all work complies with applicable laws, regulations, and institutional protocols.

PURCHASE AGREEMENT

By completing a purchase, the customer confirms that they are a qualified researcher, laboratory, educational institution, or authorized organization purchasing this product solely for lawful research purposes. The purchaser accepts full responsibility for the proper storage, handling, use, and disposal of the product, as well as compliance with all applicable local, state, and federal regulations. All sales are considered final unless otherwise stated.

About CJC-1295 with Ipamorelin

CJC-1295 and Ipamorelin are two distinct research peptides frequently studied together for their complementary effects on growth hormone signalling. CJC-1295 is a synthetic analogue of growth-hormone-releasing hormone (GHRH), studied for its action at the GHRH receptor and its role in stimulating pulsatile growth hormone release. Ipamorelin, by contrast, is a selective growth hormone secretagogue (GHS) that acts at the ghrelin receptor (GHS-R1a) — a separate signalling pathway associated with growth hormone secretion. For a closer look at Ipamorelin on its own, see our standalone Ipamorelin research peptide.

Because the two compounds act on different receptors within the same broader growth-hormone-release pathway, researchers have studied their combined use to examine complementary signalling effects compared with either compound investigated alone. This pairing is one of the more frequently referenced combinations in growth hormone secretagogue research literature.

This product supplies CJC-1295 and Ipamorelin together as a combined 10 mg vial of lyophilised powder. For related compounds, see our peptide Compound Library.

What Effects of CJC-1295 with Ipamorelin Are Studied?

Research into CJC-1295 and Ipamorelin, individually and in combination, has focused on their influence on growth hormone release and related signalling pathways. CJC-1295's GHRH-receptor activity has been studied for its effect on the frequency and amplitude of growth hormone pulses, while Ipamorelin's ghrelin-receptor activity has been examined for its comparatively selective growth hormone stimulation, with limited reported activity at receptors linked to cortisol and prolactin release.

Combined use of GHRH analogues and selective secretagogues is a recurring theme in growth hormone secretagogue literature, where researchers compare single-compound and combined-compound signalling responses.

These are research findings relevant to laboratory and preclinical study, not confirmed outcomes in humans. Reliable Research Labs supplies CJC-1295 with Ipamorelin exclusively for qualified laboratory research — nothing on this page describes, recommends or implies dosing, administration, or an outcome from using this product.

Customer Reviews

You may also like